""Of course it's good for the business, but I'm also passionate about this stuff." Tingle's approach reflects a commitment to improving health spans rather than just focusing on longevity."
"The global biohacking market is expected to more than double to $69 billion in the next four years, indicating a growing interest in technologies aimed at extending life."
Brooks Tingle, CEO of John Hancock, advocates for a shift in life insurance from transactional to health span enhancement. With the median age in the U.S. nearing 40 and a growing elderly population, there are both challenges and opportunities. Americans over 55 control significant wealth and are investing in longevity technologies. However, many are unprepared for extended lifespans. The biohacking market is rapidly expanding, with predictions of significant growth and ambitious claims about human immortality.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]